A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility - PubMed (original) (raw)
doi: 10.1001/archpsyc.1981.01780260017001.
M Feinberg, J F Greden, J Tarika, A A Albala, R F Haskett, N M James, Z Kronfol, N Lohr, M Steiner, J P de Vigne, E Young
- PMID: 7458567
- DOI: 10.1001/archpsyc.1981.01780260017001
A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility
B J Carroll et al. Arch Gen Psychiatry. 1981 Jan.
Abstract
Four hundred thirty-eight subjects underwent an overnight dexamethasone suppression test (DST) to standardize the test for the diagnosis of melancholia (endogenous depression). Abnormal plasma cortisol concentrations within 24 hours after dexamethasone administration occurred almost exclusively in melancholic patients. The best plasma cortisol criterion concentration, above which a DST result may be considered abnormal, was 5 microgram/dL. The optimal dose of dexamethasone was 1 rather than 2 mg. Two blood samples obtained at 4 and 11 PM after dexamethasone administration detected 98% of the abnormal test results. This version of the DST identified melancholic patients with a sensitivity of 67% and a specificity of 96%. Baseline nocturnal plasma cortisol concentrations were not useful. Abnormal DST results were found with similar frequency among outpatients and inpatients with melancholia; but they were not related to age, sex, recent use of psychotropic drugs, or severity of depressive symptoms. Extensive evidence validates this practical test for the diagnosis of melancholia.
Similar articles
- Comparison of plasma cortisol and corticosterone in the dexamethasone suppression test for melancholia.
Wilens TE, Ritchie JC, Carroll BJ. Wilens TE, et al. Psychoneuroendocrinology. 1984;9(1):45-55. doi: 10.1016/0306-4530(84)90021-0. Psychoneuroendocrinology. 1984. PMID: 6739664 - The dexamethasone suppression test in patients with mood disorders.
Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR Jr, Weissenburger JE, Crowley GT, Khatami M, Vasavada N. Rush AJ, et al. J Clin Psychiatry. 1996 Oct;57(10):470-84. doi: 10.4088/jcp.v57n1006. J Clin Psychiatry. 1996. PMID: 8909334 Review. - Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
Kumar A, Alcser K, Grunhaus L, Greden JF. Kumar A, et al. Biol Psychiatry. 1986 May;21(5-6):436-44. doi: 10.1016/0006-3223(86)90185-x. Biol Psychiatry. 1986. PMID: 3697434 - Specificity of the salivary cortisol dexamethasone suppression test across psychiatric diagnoses.
Copolov DL, Rubin RT, Stuart GW, Poland RE, Mander AJ, Sashidharan SP, Whitehouse AM, Blackburn IM, Freeman CP, Blackwood DH. Copolov DL, et al. Biol Psychiatry. 1989 Apr 1;25(7):879-93. doi: 10.1016/0006-3223(89)90268-0. Biol Psychiatry. 1989. PMID: 2720003 - [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
Matsunaga H, Sarai M. Matsunaga H, et al. Seishin Shinkeigaku Zasshi. 2000;102(4):367-98. Seishin Shinkeigaku Zasshi. 2000. PMID: 10892305 Review. Japanese.
Cited by
- The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians.
Varghese FP, Brown ES. Varghese FP, et al. Prim Care Companion J Clin Psychiatry. 2001 Aug;3(4):151-155. doi: 10.4088/pcc.v03n0401. Prim Care Companion J Clin Psychiatry. 2001. PMID: 15014598 Free PMC article. - On the relation among psychological distress, diabetes-related health behavior, and level of glycosylated hemoglobin in type I diabetes.
Metsch J, Tillil H, Köbberling J, Sartory G. Metsch J, et al. Int J Behav Med. 1995;2(2):104-17. doi: 10.1207/s15327558ijbm0202_2. Int J Behav Med. 1995. PMID: 16250780 - Salivary alpha-amylase and cortisol responsiveness following electrically stimulated physical stress in bipolar disorder patients.
Tanaka Y, Maruyama Y, Ishitobi Y, Kawano A, Ando T, Ikeda R, Inoue A, Imanaga J, Okamoto S, Kanehisa M, Ninomiya T, Tsuru J, Akiyoshi J. Tanaka Y, et al. Neuropsychiatr Dis Treat. 2013;9:1899-905. doi: 10.2147/NDT.S48722. Epub 2013 Dec 6. Neuropsychiatr Dis Treat. 2013. PMID: 24353422 Free PMC article. - DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.
Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, Terao T. Fuchikami M, et al. PLoS One. 2011;6(8):e23881. doi: 10.1371/journal.pone.0023881. Epub 2011 Aug 30. PLoS One. 2011. PMID: 21912609 Free PMC article. - In search of HPA axis dysregulation in child and adolescent depression.
Guerry JD, Hastings PD. Guerry JD, et al. Clin Child Fam Psychol Rev. 2011 Jun;14(2):135-60. doi: 10.1007/s10567-011-0084-5. Clin Child Fam Psychol Rev. 2011. PMID: 21290178 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical